abstract |
The present invention refers to drugs used for tissue necrosis due to blood deficiency and oxygen deficiency, and the drugs include amniotic fluid or extracts thereof from non-human animals, especially poultry and non-human mammals, and mediators that can be accepted in a pharmacy arbitrarily selected. . The drug combination of the present invention promotes cell growth, enhances cardiac function after myocardial infarction, and promotes regeneration of heart cells after myocardial infarction. |